期刊文献+

基于全基因组测序结核分枝杆菌宿主内异质性的鉴定及其研究进展 被引量:2

Updates on the application of whole-genome sequencing for within-host heterogeneity of Mycobacterium tuberculosis
下载PDF
导出
摘要 结核分枝杆菌(Mycobacterium tuberculosis,MTB)作为引发结核病的主要病原体,其遗传多态性相对保守,随着二代全基因组测序技术的发展和普及,在不同宿主甚至同一宿主内都可观察到MTB菌株丰富的遗传异质性。宿主内异质性的成因包括不同菌株的多重(混合)感染和同一菌株的微进化。宿主内异质性的发生机制及其对MTB耐药、传播和诊疗等方面的影响及应用尚未完全清楚。本文综述了MTB宿主内遗传异质性的鉴定及相关研究进展,以期为结核病防控工作提供更多新思路。 Tuberculosis(TB)is an infectious disease caused by the Mycobacterium tuberculosis(MTB).The genetic polymorphism of the MTB complex is relatively conservative.With the impressive progress in the field of next generation sequencing(NGS)and the whole-genome sequencing(WGS)analysis,vast genetic heterogeneity has been observed in MTB isolates from different hosts and even within the same host.The reasons for this phenomenon are complex,at least including multiple or mixed infections of different strains and microevolution of the same strain within the host.Still,its mechanism and role in drug resistance,transmission,diagnosis and treatment of TB are not fully understood.This article reviews the identification and current research progress of the within-host genetic heterogeneity of MTB.
作者 张睿 刘艳萍 钱军 方强林 杨崇广 Zhang Rui;Liu Yanping;Qian Jun;Fang Qianglin;Yang Chongguang(School of Public Health(Shenzhen),Shenzhen Campus of Sun Yat-sen University,Shenzhen 518107,China)
出处 《中国防痨杂志》 CAS CSCD 2022年第11期1199-1204,共6页 Chinese Journal of Antituberculosis
基金 深圳南山区高水平医学团队项目(SZSM202103008)。
关键词 分枝杆菌 结核 遗传异质性 全基因组测序 感染 综述 Mycobacterium tuberculosis Genetic heterogeneity Whole-genome sequencing Infection Review
  • 相关文献

参考文献3

二级参考文献59

  • 1朱艳霞,吕君,王小平.以患者为中心的护理措施对肝癌经皮股动脉化疗患者癌因性疲乏的影响[J].疾病监测与控制,2020(2):145-147. 被引量:2
  • 2唐神结,肖和平.耐多药结核病的综合治疗[J].中华结核和呼吸杂志,2003,26(11):715-718. 被引量:64
  • 3端木宏谨.耐药结核病的流行和监测[J].中华结核和呼吸杂志,2006,29(8):509-511. 被引量:38
  • 4World Health Organization. Global tuberculosis report 2012 [ R ] . Geneva: WHO, 2012.
  • 5World Health Organization. Muhidrug and extensively drug-resistant TB (M/XDR- TB): 2010 global report on surveillance and response[ R]. Geneva: WHO, 2010.
  • 6World Health Organization. Treatment of tuberculosis: guidelines [ R ] . Geneva: WHO, 2010.
  • 7Almeida Da Silva PE, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs[ J ]. J Antimicrob Chemother, 2011,66: 1417-1430.
  • 8Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay [ J ]. J Clin Microbiol, 2010, 48: 2495-2501.
  • 9Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance [ J ]. N Engl J Med, 2010, 363: 1005-1015.
  • 10Maruri F, Sterling TR, Kaiga AW, et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system[J]. J Antimicrob Chemother, 2012, 67: 819-831.

共引文献40

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部